Navigation Links
Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008
Date:4/9/2008

he conversion rate was dose-dependent.

The Congressional briefing, sponsored by Congressman James Langevin (D-RI), provides an opportunity for members of Congress and their staff to meet with experts, hear a general overview of spinal cord research and to receive an update on the latest advancements and therapeutic interventions. Dr. Hurtt will be joined by Dr. Damien Pearse of the Miami Project, Dr. Stephen Davies, University of Colorado, Dr. Wise Young, Rutgers University and Dr. Simon Archibald, Integra LifeSciences.

Dr. Hurtt commented, "As we continue to develop CETHRIN with the aim of providing a first-ever therapeutic option for nerve repair to patients with acute spinal cord injury, we are committed to the support of the excellent work of the SCI advocacy groups. These groups reach out to patients, care-givers, professional societies and the general public providing valuable educational, quality of life and often research funding opportunities. We are most pleased to have been invited to the 'Working 2 Walk' Conference and to assist their legislative efforts in the U.S. Congress."

About Working 2 Walk

The third annual "Working 2 Walk" Conference to be held April 13-15, 2008 in Washington, DC is a joint project of Unite 2 Fight Paralysis, a nationwide patient advocacy organization, and the Kennedy Krieger Institute of Baltimore, leaders in rehabilitative strategies that restore function after spinal cord injury. The "Working 2 Walk" Science and Educational Symposium provides a setting for researchers, clinicians and the spinal cord injury community to collaborate on strategies necessary to achieve a cure for paralysis.

About Alseres

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
8. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/942kh3/micro_market ) ... Market Monitor: North American Dermatology Diagnostic Devices Market" ... http://photos.prnewswire.com/prnh/20130307/600769 Cosmetic surgeries ... resulted in fueling the overall demand of the ... these dermatology devices is to assist in identifying ...
(Date:12/19/2014)... 2014 Capnia, Inc. (NASDAQ: ... diagnostics based on its proprietary Sensalyze™ Technology Platform ... financial results for the third quarter and nine ... the completion of our initial public offering (IPO), ... recently initiated CoSense® commercial launch," said Anish Bhatnagar, ...
(Date:12/19/2014)... Since last month,s FBI shutdown of online drug marketplace ... online black market for illegal drugs - Evolution Marketplace ... drugs and other illegal items.  New numbers from the ... lowering the numbers of drugs and illegal items available ... But some new sites that have emerged as potentially ...
Breaking Medicine Technology:Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3
... Call -- SHANGHAI, Oct. 25 /PRNewswire-Asia/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... Endologix, Inc. (Nasdaq: ELGX ), ... announced today that John McDermott, President and Chief ... Oppenheimer 21st Annual Healthcare Conference in New York, ... p.m. ETAn audio Web cast of the Company,s ...
Cached Medicine Technology:WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call 2WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call 3WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call 4WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call 5WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call 6WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call 7WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call 8
(Date:12/22/2014)... 22, 2014 Coral Gables is preparing to ... Lice Troopers, with its new clinic location set to open ... the hassle out of dealing with this common childhood parasite ... their two salon clinic locations in South Florida, or in ... The decision to expand developed naturally out of the demand ...
(Date:12/22/2014)... Harrisburg, NC (PRWEB) December 22, 2014 ... contain the current Ebola virus epidemic are ... by U.S. government agencies, nongovernmental organizations (NGOs) ... solutions remains ongoing, healthcare workers, emergency responders, ... advanced technologies such as the CmTP ...
(Date:12/22/2014)... Super Saturday, the last Saturday before ... the busiest day in the 2014 holiday shopping season. ... had a steady pre-Christmas stream of customers, ready to ... , “I definitely intend to take advantage…of the recreational ... who was enjoying The Grass Station’s holiday sale on ...
(Date:12/22/2014)... Georgia (PRWEB) December 22, 2014 The MedTech ... Inc, a wholly owned subsidiary of PartnerTech AB of ... U.S. having recently achieved additional ISO Certification. , All signs ... in employment and the likelihood of a repeal of the ... Act . The industry is anticipating annual growth of 9.3% ...
(Date:12/22/2014)... Dallas, Texas (PRWEB) December 22, 2014 Luxury ... with Community Partners of Dallas to provide logistics ... A Dallas-based company, Peacock Alley has a long history of ... works. The additional sponsors of this year's Toy Drive were ... time to give back than the holidays. Providing gifts to ...
Breaking Medicine News(10 mins):Health News:Professional In-Home All-Natural Lice Removal Service Expands to Coral Gables and surrounding areas. 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:PartnerTech Inc. Poised for Growth in MedTech 2Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2
... The following is a,statement by Lois Aronstein, AARP ... including a $400 million Housing,Opportunity Fund to improve the ... be used to provide needed opportunities,for low- and moderate-income ... The program will be administered by the State of ...
... toward Blue Cross Blue Shield Members, PITTSBURGH, ... today that it has received a Brand Excellence ... (BCBSA). The annual awards honor Blue,Cross and Blue ... the,overall Blue Cross and Blue Shield Brand image., ...
... eliminate the prescription drug expense paid by poor seniors ... Capitol Hill., Reps. Lloyd Doggett (D-25th TX) and ... sponsoring HR 5604, the Medicare Part D Home,and Community ... an apparent oversight in the Medicare Part D Prescription,Drug ...
... Marathon Mark Leventhal, Esq.,Founder and President ... -- the first in the nation ... an attorney -- is featured on,the cover ... ("YL") in an article,entitled "Accessible Accountability: Attorney,s ...
... at the Massachusetts General Hospital (MGH) have initiated a ... The trial is exploring whether the promising results ... be applied in human diabetes. Faustmans previous studies have ... closely resembles type 1 diabetes in humans can be ...
... say the next major disease like HIV/AIDS or ... of developing countries concentrated along the equator. ... of a potential outbreak., ,Using global databases and ... diseases, the researchers -- from the Consortium for ...
Cached Medicine News:Health News:Highmark Receives Prestigious Brand Excellence Award 2Health News:ALFA Aims to Provide Relief to Seniors 2Health News:Leventhal Weight Loss Incorporated President Featured on Cover of Young Lawyer 2Health News:MGH initiates phase I diabetes trial 2Health News:Scientists say tropics are next emerging disease hotspot 2Health News:Scientists say tropics are next emerging disease hotspot 3
... Care Xpress is an innovative, stat analyzer ... hematology with on-board co-oximetry and integrated data ... Measured tests include pH, PCO 2 , ... and hemoglobin, sodium, potassium, chloride, ionized calcium, ...
... Kohden developed the world's first ... was completely AC powered in ... developed a number of standard ... measuring systems, such as a ...
... in Digital EEG ,The company that ... presents the latest addition to the ... This innovative system incorporates the latest ... information management to offer you unprecedented ...
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: